Migraine Solidarity Day - June 21

You may already know that migraine disease is more common than Alzheimer's disease, Parkinson's disease, epilepsy and multiple sclerosis combined.  And despite that fact, it receives a small fraction of the available neuroscience research funding. Not  surprisingly there are a very small number of neuroscience researchers who decide to take on migraine as a project, or devote a laboratory or professional lifetime to it.

Taking Stock

As an ardent follower of the recent advances in the understanding and treatment of migraine disorders I am impressed with the great strides made over the last 24 months. It is remarkable that since the 1990s and the introduction of triptans, so much significant work in both prevention and treatment is now coming to fruition. So why now? What forces conspired to move the migraine agenda forward? I think it is important that we look at this question in an effort to ascertain why these positive results have occurred and our agenda has continued to gain traction.

Traumatic Brain Injuries and Migraines

Traumatic Brain Injury and Migraines: Civilian and Military Implications

Consideration of this subject brings us to the intersection of some of the most critical issues challenging the migraine treatment community. With Memorial Day fading in the rear view mirror, we at AMD began to reflect on a number of these issues and thought looking at Traumatic Brain Injury (TBI) may be as good a place as any to enter the ongoing controversy. Yes, TBI, because of its startling presence in both the military and civilian worlds, TBI could prove a very opportune place indeed.

Migraine: Myth versus Reality

“There is no condition of such magnitude that is as shrouded in myth, misinformation, and mistreatment as is this condition [Migraine], and there are few conditions which are as disabling during the acute attack.”
-Dr. Joel R. Saper, M.D., F.A.C.P., Director, Michigan Head-Pain & Neurological Institute